3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
2
Congenital Abnormalities
2
Brain Neoplasms
2
Wilms Tumor
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Recurrence
1
Radiation Injuries
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Osteosarcoma
1
Neutropenia
1
Neurotoxicity Syndromes
1
Neuroendocrine Tumors
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Juvenile
1
Interventions
Cyclophosphamide
37
fludarabine phosphate
32
Peripheral Blood Stem Cell Transplantation
30
Busulfan
28
Tacrolimus
24
Antilymphocyte Serum
23
Mycophenolic Acid
21
Filgrastim
21
Radiotherapy
20
Methotrexate
19
Cyclosporine
19
Melphalan
15
Methylprednisolone
14
Etoposide
14
Whole-Body Irradiation
13
Cord Blood Stem Cell Transplantation
11
Therapeutics
9
Psychiatric Rehabilitation
9
Flow Cytometry
8
sargramostim
7
Sirolimus
7
Cytarabine
7
Alemtuzumab
6
Polymerase Chain Reaction
5
Granulocyte Colony-Stimulating Factor
5
thymoglobulin
4
aldesleukin
4
Thiotepa
4
Specimen Handling
4
Early Intervention, Educational
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
×
Lithium Carbonate
×
Clear all
NCT00408681
2017-03-07
GVHD
Fred Hutchinson Cancer Center
Phase NA
Completed
20 enrolled
27 charts